Incidental Fallopian Tube Adenocarcinoma Managed using Robotic Staging SurgeryWang CW, Chen CH, Chen HH and Liu WM*
Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- *Corresponding Author:
- Liu WM
Department of Obstetrics and Gynecology, School of Medicine
College of Medicine, Taipei Medical University, Taipei, Taiwan
E-mail: [email protected]
Received: November 30, 2015; Accepted: January 28, 2016; Published: January 30, 2016
Citation: Wang CW, Chen CH, Chen HH, Liu WM (2016) Incidental Fallopian Tube Adenocarcinoma Managed using Robotic Staging Surgery. Adv Robot Autom 5:138. doi:10.4172/2168-9695.1000138
Copyright: © 2016 Wang CW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Primary fallopian tube carcinoma is an uncommon gynecological malignancy. Management of primary fallopian tube carcinoma using a robotic-assisted approach is also rare. We have described here two cases of adenocarcinoma located in the fallopian tubes that were managed using robotic-assisted staging surgery, followed by subsequent serial chemotherapy. The surgical procedure consisted of a total hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvi lymph node dissection, para-aortic lymph node dissection, appendectomy, omentectomy, peritoneal biopsies, and ascites cytology. After surgery, a test for CA-125 level and a computed tomography (CT) evaluation were conducted every 3 and 6 months, respectively. In Case I, the patient received 6 cycles of chemotherapy consisting of cisplatin and paclitaxel after surgery, and CA-125 level decreased from 55.9 U/mL to 9.5 U/mL over 6 months. At 16 months after surgery, a follow-up CT scan revealed no evidence of local recurrence. In Case II, the patient received 11 cycles of chemotherapy including cisplatin and paclitaxel, and CA-125 level decreased from 52.1 U/mL to 11.1 U/mL over 12 months. At 20 months after surgery, a follow-up CT scan revealed no evidence of local recurrence. In conclusion, robotic-assisted staging surgery is a feasible approach for treating incidentally located tumors in the fallopian tubes.